Integra LifeSciences Holdings Gross Margin 2010-2024 | IART

Current and historical gross margin for Integra LifeSciences Holdings (IART) over the last 10 years. The current gross profit margin for Integra LifeSciences Holdings as of March 31, 2024 is %.
Integra LifeSciences Holdings Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-03-31 $1.53B $0.86B 56.12%
2023-12-31 $1.54B $0.88B 57.37%
2023-09-30 $1.54B $0.91B 58.88%
2023-06-30 $1.55B $0.93B 60.00%
2023-03-31 $1.56B $0.97B 62.04%
2022-12-31 $1.56B $0.97B 62.26%
2022-09-30 $1.57B $0.97B 61.88%
2022-06-30 $1.57B $0.97B 62.12%
2022-03-31 $1.56B $0.96B 61.79%
2021-12-31 $1.54B $0.94B 61.18%
2021-09-30 $1.53B $0.94B 61.40%
2021-06-30 $1.51B $0.93B 61.63%
2021-03-31 $1.38B $0.84B 61.25%
2020-12-31 $1.37B $0.85B 62.03%
2020-09-30 $1.38B $0.86B 62.05%
2020-06-30 $1.39B $0.86B 61.72%
2020-03-31 $1.51B $0.94B 62.37%
2019-12-31 $1.52B $0.95B 62.78%
2019-09-30 $1.51B $0.94B 62.68%
2019-06-30 $1.49B $0.93B 62.36%
2019-03-31 $1.48B $0.92B 62.37%
2018-12-31 $1.47B $0.90B 61.28%
2018-09-30 $1.46B $0.89B 60.70%
2018-06-30 $1.37B $0.84B 61.20%
2018-03-31 $1.29B $0.79B 61.62%
2017-12-31 $1.19B $0.75B 63.25%
2017-09-30 $1.08B $0.70B 65.24%
2017-06-30 $1.05B $0.69B 65.52%
2017-03-31 $1.01B $0.66B 65.38%
2016-12-31 $0.99B $0.64B 64.82%
2016-09-30 $0.98B $0.62B 63.87%
2016-06-30 $0.95B $0.60B 63.27%
2016-03-31 $0.92B $0.58B 63.25%
2015-12-31 $0.88B $0.56B 62.85%
2015-09-30 $0.80B $0.50B 62.52%
2015-06-30 $0.77B $0.48B 62.71%
2015-03-31 $0.79B $0.49B 62.17%
2014-12-31 $0.80B $0.49B 61.98%
2014-09-30 $0.73B $0.45B 61.52%
2014-06-30 $0.74B $0.45B 61.22%
2014-03-31 $0.72B $0.43B 60.56%
2013-12-31 $0.70B $0.42B 59.83%
2013-09-30 $0.83B $0.51B 60.84%
2013-06-30 $0.83B $0.51B 61.06%
2013-03-31 $0.83B $0.51B 61.73%
2012-12-31 $0.83B $0.52B 62.41%
2012-09-30 $0.82B $0.51B 61.71%
2012-06-30 $0.81B $0.50B 61.45%
2012-03-31 $0.80B $0.49B 61.26%
2011-12-31 $0.78B $0.48B 61.67%
2011-09-30 $0.77B $0.48B 62.73%
2011-06-30 $0.76B $0.48B 63.05%
2011-03-31 $0.74B $0.47B 63.43%
2010-12-31 $0.73B $0.46B 63.17%
2010-09-30 $0.72B $0.46B 63.62%
2010-06-30 $0.71B $0.45B 63.84%
2010-03-31 $0.70B $0.44B 63.88%
2009-12-31 $0.68B $0.44B 64.13%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.276B $1.542B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.696B 25.77
Intuitive Surgical (ISRG) United States $153.425B 92.43
Edwards Lifesciences (EW) United States $53.535B 34.84
DexCom (DXCM) United States $46.159B 69.92
Alcon (ALC) Switzerland $44.103B 31.60
IDEXX Laboratories (IDXX) United States $40.960B 48.01
IQVIA Holdings (IQV) United States $39.025B 22.64
STERIS (STE) Ireland $21.680B 25.32
SONOVA HOLDING (SONVY) Switzerland $18.305B 0.00
Waters (WAT) United States $17.203B 25.28
Hologic (HOLX) United States $16.852B 18.85
Fresenius Medical Care AG KGaA (FMS) Germany $11.467B 13.38
Sysmex ADR (SSMXY) Japan $9.736B 30.53
Teleflex (TFX) United States $9.518B 14.81
Globus Medical (GMED) United States $9.070B 26.59
Masimo (MASI) United States $6.934B 39.88
Penumbra (PEN) United States $6.801B 77.29
Glaukos (GKOS) United States $5.624B 0.00
TransMedics (TMDX) United States $4.743B 450.00
Integer Holdings (ITGR) United States $3.878B 23.43
PROCEPT BioRobotics (PRCT) United States $3.093B 0.00
LivaNova (LIVN) United Kingdom $3.012B 17.89
Tandem Diabetes Care (TNDM) United States $2.750B 0.00
Inari Medical (NARI) United States $2.684B 0.00
Nihon Kohden (NHNKY) Japan $2.654B 14.06
Elekta AB (EKTAY) Sweden $2.388B 18.31
RxSight (RXST) United States $2.070B 0.00
Veracyte (VCYT) United States $1.664B 0.00
Alphatec Holdings (ATEC) United States $1.434B 0.00
Silk Road Medical (SILK) United States $1.063B 0.00
Artivion (AORT) United States $0.963B 92.40
AVANOS MEDICAL, INC (AVNS) United States $0.893B 17.37
OPKO Health (OPK) United States $0.864B 0.00
OrthoPediatrics (KIDS) United States $0.697B 0.00
Pulse Biosciences (PLSE) United States $0.614B 0.00
IRadimed (IRMD) United States $0.539B 30.16
SiBone (SIBN) United States $0.503B 0.00
Mesa Laboratories (MLAB) United States $0.495B 14.67
ORTHOFIX MEDICAL INC (OFIX) United States $0.477B 0.00
Paragon 28 (FNA) United States $0.476B 0.00
Pacific Biosciences Of California (PACB) United States $0.428B 0.00
Treace Medical Concepts (TMCI) United States $0.363B 0.00
Sight Sciences (SGHT) United States $0.316B 0.00
Nevro (NVRO) United States $0.316B 0.00
AxoGen (AXGN) United States $0.298B 0.00
Tactile Systems Technology (TCMD) United States $0.264B 9.05
Semler Scientific (SMLR) United States $0.249B 12.63
CVRx (CVRX) United States $0.240B 0.00
AngioDynamics (ANGO) United States $0.237B 0.00
Delcath Systems (DCTH) United States $0.226B 0.00
EDAP TMS S.A (EDAP) France $0.196B 0.00
NeuroPace (NPCE) United States $0.190B 0.00
Inogen (INGN) United States $0.185B 0.00
908 Devices (MASS) United States $0.182B 0.00
Accuray (ARAY) United States $0.182B 0.00
Alpha Tau Medical (DRTS) Israel $0.157B 0.00
ClearPoint Neuro (CLPT) United States $0.152B 0.00
Atossa Genetics (ATOS) United States $0.140B 0.00
Yubo Biotech (YBGJ) China $0.132B 0.00
KORU Medical Systems (KRMD) United States $0.108B 0.00
Spectral Diagnostics (EDTXF) Canada $0.099B 0.00
Sensus Healthcare (SRTS) United States $0.085B 17.90
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.063B 0.00
EnVVeno Medical (NVNO) United States $0.062B 0.00
Hyperfine (HYPR) United States $0.059B 0.00
SEP Acquisition (SEPA) United States $0.056B 0.00
Neuronetics (STIM) United States $0.054B 0.00
T2 Biosystems (TTOO) United States $0.051B 0.00
LENSAR (LNSR) United States $0.049B 0.00
Envoy Medical (COCH) United States $0.047B 0.00
Lucid Diagnostics (LUCD) United States $0.036B 0.00
Precision Optics (POCI) United States $0.036B 0.00
ReWalk Robotics (LFWD) Israel $0.036B 0.00
Vicarious Surgical (RBOT) United States $0.035B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Accelerate Diagnostics (AXDX) United States $0.028B 0.00
Autonomix Medical (AMIX) United States $0.022B 0.00
Pixie Dust Technologies (PXDT) Japan $0.021B 0.00
Aspira Women's Health (AWH) United States $0.021B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.018B 0.00
QT Imaging Holdings (QTI) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
NexGel (NXGL) United States $0.013B 0.00
PAVmed (PAVM) United States $0.008B 0.00
Venus Concept (VERO) Canada $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00